477 related articles for article (PubMed ID: 34605352)
21. A Comparative Study of Children with MIS-C between Admitted to the Pediatric Intensive Care Unit and Pediatric Ward: A One-Year Retrospective Study.
Kıymet E; Böncüoğlu E; Şahinkaya Ş; Cem E; Çelebi MY; Düzgöl M; Kara AA; Arıkan KÖ; Vuran GT; Yılmazer MM; Sandal ÖS; Ağın H; Pirinç N; Bayram N; Devrim İ
J Trop Pediatr; 2021 Dec; 67(6):. PubMed ID: 34931251
[TBL] [Abstract][Full Text] [Related]
22. Mucocutaneous disease and related clinical characteristics in hospitalized children and adolescents with COVID-19 and multisystem inflammatory syndrome in children.
Rekhtman S; Tannenbaum R; Strunk A; Birabaharan M; Wright S; Garg A
J Am Acad Dermatol; 2021 Feb; 84(2):408-414. PubMed ID: 33323343
[TBL] [Abstract][Full Text] [Related]
23. Multisystem Inflammatory Syndrome in Children Associated with COVID-19 in a Tertiary Level Hospital in Portugal.
Vieira de Melo J; Valsassina R; Garcia AM; Silva T; Gouveia C; Brito MJ
Acta Med Port; 2022 Dec; 35(12):881-890. PubMed ID: 35639579
[TBL] [Abstract][Full Text] [Related]
24. Pediatric Multisystemic Inflammatory Syndrome Temporarily associated with COVID-19: Clinical characteristics and management in a Pediatric Critical Care Unit.
Yagnam R F; Izquierdo C G; Villena M R; González M C; Drago-T M
Andes Pediatr; 2021 Jun; 92(3):395-405. PubMed ID: 34479246
[TBL] [Abstract][Full Text] [Related]
25. Multisystem inflammatory syndrome in children (MIS-C) during SARS-CoV-2 pandemic in Brazil: a multicenter, prospective cohort study.
Lima-Setta F; Magalhães-Barbosa MC; Rodrigues-Santos G; Figueiredo EADN; Jacques ML; Zeitel RS; Sapolnik R; Borges CTDS; Lanziotti VS; Castro REV; Bellinat APN; Silva TPD; Oliveira FRC; Reis BCSD; Castro NAASR; Macedo JHGC; Scarlato ACCP; Riveiro PM; Mota ICFD; Lorenzo VB; Lucena NML; Azevedo ZMA; Cunha AJLA; Prata-Barbosa A;
J Pediatr (Rio J); 2021; 97(3):354-361. PubMed ID: 33186512
[TBL] [Abstract][Full Text] [Related]
26. SARS-CoV-2 infection in children, clinical characteristics, diagnostic findings and therapeutic interventions at a tertiary care center in Riyadh, Saudi Arabia.
Alharbi M; Kazzaz YM; Hameed T; Alqanatish J; Alkhalaf H; Alsadoon A; Alayed M; Hussien SA; Shaalan MA; Al Johani SM
J Infect Public Health; 2021 Apr; 14(4):446-453. PubMed ID: 33765595
[TBL] [Abstract][Full Text] [Related]
27. Pediatric Inflammatory Multisystem Syndrome Associated With SARS-CoV-2: A Case Series Quantitative Systematic Review.
Bustos B R; Jaramillo-Bustamante JC; Vasquez-Hoyos P; Cruces P; Díaz F
Pediatr Emerg Care; 2021 Jan; 37(1):44-47. PubMed ID: 33181794
[TBL] [Abstract][Full Text] [Related]
28. Multisystem Inflammatory Syndrome Following SARS-CoV-2 Infection in Children: One Year after the Onset of the Pandemic in a High-Incidence Area.
Fabi M; Filice E; Biagi C; Andreozzi L; Palleri D; Mattesini BE; Rizzello A; Gabrielli L; Ghizzi C; Di Luca D; Caramelli F; De Fanti A; Lanari M
Viruses; 2021 Oct; 13(10):. PubMed ID: 34696451
[TBL] [Abstract][Full Text] [Related]
29. COVID-19 related multisystem inflammatory syndrome in children (MIS-C): a case series from a tertiary care pediatric hospital in Qatar.
Hasan MR; Al Zubaidi K; Diab K; Hejazi Y; Bout-Tabaku S; Al-Adba B; Al Maslamani E; Janahi M; Roscoe D; Lopez AP; Tang P
BMC Pediatr; 2021 Jun; 21(1):267. PubMed ID: 34103044
[TBL] [Abstract][Full Text] [Related]
30. Multisystem inflammatory syndrome in children (MIS-C): Report of the clinical and epidemiological characteristics of cases in Santiago de Chile during the SARS-CoV-2 pandemic.
Torres JP; Izquierdo G; Acuña M; Pavez D; Reyes F; Fritis A; González R; Rivacoba C; Contardo V; Tapia LI
Int J Infect Dis; 2020 Nov; 100():75-81. PubMed ID: 32861823
[TBL] [Abstract][Full Text] [Related]
31. Therapeutic plasma exchange: A potential management strategy for critically ill MIS-C patients in the pediatric intensive care unit.
Emeksiz S; Özcan S; Perk O; Uyar E; Çelikel Acar B; Kibar Gül AE; Özkaya Parlakay A; Özbek N; Ekici Tekin Z; Coşkun S; Aydın F; Çelikel E; Kavurt AV; Ece İ; Ok Bozkaya İ; Ertürk A; Güney D; Şenel E
Transfus Apher Sci; 2021 Jun; 60(3):103119. PubMed ID: 33836934
[TBL] [Abstract][Full Text] [Related]
32. Characteristics and Outcomes of US Children and Adolescents With Multisystem Inflammatory Syndrome in Children (MIS-C) Compared With Severe Acute COVID-19.
Feldstein LR; Tenforde MW; Friedman KG; Newhams M; Rose EB; Dapul H; Soma VL; Maddux AB; Mourani PM; Bowens C; Maamari M; Hall MW; Riggs BJ; Giuliano JS; Singh AR; Li S; Kong M; Schuster JE; McLaughlin GE; Schwartz SP; Walker TC; Loftis LL; Hobbs CV; Halasa NB; Doymaz S; Babbitt CJ; Hume JR; Gertz SJ; Irby K; Clouser KN; Cvijanovich NZ; Bradford TT; Smith LS; Heidemann SM; Zackai SP; Wellnitz K; Nofziger RA; Horwitz SM; Carroll RW; Rowan CM; Tarquinio KM; Mack EH; Fitzgerald JC; Coates BM; Jackson AM; Young CC; Son MBF; Patel MM; Newburger JW; Randolph AG;
JAMA; 2021 Mar; 325(11):1074-1087. PubMed ID: 33625505
[TBL] [Abstract][Full Text] [Related]
33. Ten-month follow-up of patients with covid-19 temporally related multi-system inflammatory syndrome in children: the experience of the children hospital of Palermo.
Maggio MC; Giordano S; Failla MC; Campione MG; Alaimo A; Corsello G
Ital J Pediatr; 2023 Mar; 49(1):37. PubMed ID: 36959663
[TBL] [Abstract][Full Text] [Related]
34. SARS-CoV-2-associated multisystem inflammatory syndrome in children: clinical manifestations and the role of infliximab treatment.
Abdel-Haq N; Asmar BI; Deza Leon MP; McGrath EJ; Arora HS; Cashen K; Tilford B; Charaf Eddine A; Sethuraman U; Ang JY
Eur J Pediatr; 2021 May; 180(5):1581-1591. PubMed ID: 33452570
[TBL] [Abstract][Full Text] [Related]
35. Early combination therapy with immunoglobulin and steroids is associated with shorter ICU length of stay in Multisystem Inflammatory Syndrome in Children (MIS-C) associated with COVID-19: A retrospective cohort analysis from 28 U.S. Hospitals.
Harthan AA; Nadiger M; McGarvey JS; Hanson K; Gharpure VP; Bjornstad EC; Chiotos K; Miller AS; Reikoff RA; Gajic O; Kumar V; Walkey AJ; Kashyap R; Tripathi S;
Pharmacotherapy; 2022 Jul; 42(7):529-539. PubMed ID: 35661394
[TBL] [Abstract][Full Text] [Related]
36. Clinical outcomes and safety of anakinra in the treatment of multisystem inflammatory syndrome in children: a single center observational study.
Dizon BLP; Redmond C; Gotschlich EC; Sule S; Ronis T; Vazzana KM; Sherman MA; Connor R; Bosk A; Dham N; Harahsheh AS; Wells E; DeBiasi R; Srinivasalu H
Pediatr Rheumatol Online J; 2023 Jul; 21(1):76. PubMed ID: 37525200
[TBL] [Abstract][Full Text] [Related]
37. Short-term Outcomes of Corticosteroid Monotherapy in Multisystem Inflammatory Syndrome in Children.
Villacis-Nunez DS; Jones K; Jabbar A; Fan L; Moore W; Peter AS; Henderson M; Xiang Y; Kelleman MS; Sherry W; Chandrakasan S; Oster ME; Jaggi P; Prahalad S
JAMA Pediatr; 2022 Jun; 176(6):576-584. PubMed ID: 35344042
[TBL] [Abstract][Full Text] [Related]
38. Specialty follow -up care after hospital discharge of patients with multisystem inflammatory syndrome in children associated with COVID-19 from a rural tertiary-care hospital.
Aikman I; Wright B; Applegate S; Whitfield A; Alachraf K; Sridhar S; Tumin D; Syed S
Pediatr Neonatol; 2024 May; 65(3):266-275. PubMed ID: 37926596
[TBL] [Abstract][Full Text] [Related]
39. Multisystem inflammatory syndrome in children with COVID-19.
Gottlieb M; Bridwell R; Ravera J; Long B
Am J Emerg Med; 2021 Nov; 49():148-152. PubMed ID: 34116467
[TBL] [Abstract][Full Text] [Related]
40. American College of Rheumatology Clinical Guidance for Multisystem Inflammatory Syndrome in Children Associated With SARS-CoV-2 and Hyperinflammation in Pediatric COVID-19: Version 2.
Henderson LA; Canna SW; Friedman KG; Gorelik M; Lapidus SK; Bassiri H; Behrens EM; Ferris A; Kernan KF; Schulert GS; Seo P; Son MBF; Tremoulet AH; Yeung RSM; Mudano AS; Turner AS; Karp DR; Mehta JJ
Arthritis Rheumatol; 2021 Apr; 73(4):e13-e29. PubMed ID: 33277976
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
